Evercore ISI Group Upgrades Zimmer Biomet Holdings to Outperform, Raises Price Target to $120

Benzinga · 01/05 17:55
Evercore ISI Group analyst Vijay Kumar upgrades Zimmer Biomet Holdings (NYSE:ZBH) from In-Line to Outperform and raises the price target from $94 to $120.